“High SARS-CoV-2 Seroprevalence But No Severe Course of COVID-19 Disease Among People on Opioid Agonist Treatment in Zurich: a Cross-Sectional Study”. Swiss Medical Weekly, vol. 152, no. 0102, Jan. 2022, p. w30122, https://doi.org/10.4414/SMW.2022.w30122.